Synlogic (NASDAQ:SYBX) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Shares of Synlogic, Inc. (NASDAQ:SYBX) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $1.42 and traded as high as $1.47. Synlogic shares last traded at $1.43, with a volume of 23,960 shares changing hands.

Synlogic Stock Down 0.7 %

The firm has a 50-day simple moving average of $1.42 and a 200-day simple moving average of $1.47. The stock has a market cap of $16.73 million, a PE ratio of -0.34 and a beta of 0.80.

Synlogic (NASDAQ:SYBX) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.17. On average, research analysts expect that Synlogic, Inc. will post -2.71 earnings per share for the current year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.